In a study of the nature of the renal changes in patients with mitral stenosis, lowered renal function and reduced renal circulation the effect of Apresoline, given during heart catheterization to 12 patients with mitral stenosis of varying severity, was studied. The drug was found to increase renal blood flow (and decrease arterial blood pressure), showing that the renal changes in mitral stenosis are reversible. The two effects of Apresoline were shown to be independent of each other.
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IN PATIENTS with mitral stenosis, with or without right heart failure, renal blood flow is greatly reduced. We have shown previously the existence of a certain correlation between the severity of the stenosis and degree of reduction of renal blood flow. Whether this change in renal blood flow is the result of organic vascular changes (for example, emboli) or represents a functional manifestation of the kidney's role as a regulator of the circulatory system is as yet unknown. Fever and pregnancy have so far been the only known stimuli producing increased renal blood flow in patients with hypertension and reduced renal blood flow. Neither of these procedures, however, can be used in studying the decrease of renal blood flow in patients with mitral stenosis. Reubi'2 has shown how Apresoline increases renal blood flow in patients with hypertension. We have studied the effect of this drug on patients with mitral stenosis in order to establish the character of the coexisting renal change.
METHODS AND MATERIALS
In 11 cases of mitral stenosis of varying severity and duration, the effect of Apresoline has been studied in acute experiments during which paraaminohippurate, inulin, creatinine clearance and sodium excretion were measured simultaneously with the determination of cardiac output and Para-aminohippurate and inulin were administered by intravenous drip and urine was collected every 15 minutes. After two basal periods, Apresoline and noradrenaline were added to the drip, which delivered 0.3 to 0.5 mg. of Apresoline per minute and 0.006 mg. of noradrenaline per minute, respectively. As a rule, Apresoline administration was discontinued after 30 minutes when 10 to 15 mg. had been given. Subsequently only noradrenaline was given during the following 15 to 30 minutes. Pressures were registered almost continuously and cardiac output was determined several times during these periods. Four of the patients performed light work, equaling approximately 70 kilogrammeters per minute (cycle ergometer) lying on their backs, immediately following Apresoline administration. In cases with mitral stenosis this effort ordinarily reduces renal blood flow by 15 per cent. Table 1 lists para-aminohippurate clearance, filtration fraction, cardiac output and blood pressure before and during maximal Apresoline effect. Despite the fact that noradrenaline was given to maintain arterial blood pressure, a slight decrease was recorded while paraaminohippurate clearance and cardiac output increased. Figure 1 shows that as Apresolinenoradrenaline was given there was an immediate decrease of renal blood flow and increase of blood pressure, due to noradrenaline. After Apresoline. Para-aminohippurate clearance is increased and brachial artery pressure is lowered; that is, the regular effect of exercise is supressed.
RESULTS
compared with the effect of equal effort in four comparable patients who were given 10 to 15 mg. of Apresoline.
DISCUSSION
At an early stage of this work we found that even a small amount of Apresoline may produce a marked fall in blood pressure and a shock-like state. It was found necessary, therefore, not only to give the drug in a small dose, but also to administer simultaneously a 703 blood pressure raising agent. Noradrenaline satisfactorily met this requirement. This drug increases blood pressure and reduces renal blood flow. Moreover, while it allows satisfactory control of blood pressure, it does not interfere markedly with the effect of Apresoline on the kidneys. As this effect is obtained 15 to 20 minutes after administration, a single intravenous dose was found to be impractical and an intravenous drip at the rate of 0.5 mg. Apresoline per minute was used. In the same drip 0.006 mg. noradrenaline per minute was also given. This procedure resulted in a slight fall in arterial blood pressure with a simultaneous increase of renal blood flow, in certain cases amounting to several hundred per cent of the original flow. Consequently, these experiments show that in most cases of mitral stenosis the low renal blood flow is due to reversible, functional changes. This is of great importance when deciding whether a patient should be operated upon or not. If the patient is found to have seriously damaged kidneys, an operation is, of course, of very little avail. Furthermore, Apresoline counteracts the effect which physical effort exerts on renal function in patients with mitral stenosis. Without Apresoline even slight work usually reduces renal blood flow as well as sodium excretion. When Apresoline is given, subsequent effort does not reduce renal blood flow; in some cases blood flow is even augmented. This may be due (1) to an inability of the renal vessels to react to adrenaline-noradrenaline or (2) to the fact that Apresoline inhibits the production of nervous impulses or hormones usually induced by effort. The effect of combined Apresoline-noradrenaline supports the former of these two theories.
The present investigation shows that noradrenaline suppresses the effect of Apresoline on arterial pressure while the effect on renal blood flow is unaffected. This indicates that the twofold effect of Apresoline is mediated by two independent mechanisms. Similar results have been obtained in hypertensive patients. It is improbable that the lowering of arterial pressure is secondary to the renal effect.
As has been shown earlier by Wilkinson and co-workers, Apresoline does not influence the contraction or dilatation of the pulmonary vessels.
In our study we found an increase in pulmonary pressures parallel to increase in cardiac output. This may have been due to a combined effect of noradrenaline and Apresoline. Wilkinson and co-workers found that renal blood flow generally increased proportionally less than stroke volume did and concluded that Apresoline constitutes a selective vasodilator. Only when stroke volume and renal blood flow are measured simultaneously can there be any correlation made among the values obtained. Moreover, paraaminohippurate clearance is not an exact measure of changes in renal blood flow as the renal extraction of para-aminohippurate apparently is influenced by Apresoline. Renal vein catheterization performed in two patients with hypertension, showed that para-aminohippurate extraction fell from 90 to 80 per cent with a corresponding increase of renal plasma flow from 110 to 120 per cent of paraaminohippurate clearance. In our study on patients with mitral stenosis renal plasma flow was highly dependent on the arterial pressure.
Sodium excretion showed rather large variations in our study. If arterial blood pressure was maintained at a steady or almost steady level, sodium excretion paralleled the para-aminohippurate clearance. When a marked fall in arterial blood pressure was produced, decreasing inulin clearance, the values of sodium excretion reached very low levels. Apresoline influences sodium excretion only when a marked fall in blood pressure is produced. This may be due either to reduced filtration or to changes in arterial pressure. SUMMARY 1. To 11 patients with mitral stenosis 10 to 15 mg. of Apresoline was administered by intravenous drip at the rate of 0.3 to 0.5 mg. per minute. Noradrenaline was given simultaneously at the rate of 0.006 mg. per minute to counteract the hypotonic effect of Apresoline.
2. Renal blood flow increased, in some cases by several hundred per cent, showing that the renal changes in mitral stenosis are functional and reversible. 3 . When Apresoline was given, renal blood flow was not, as otherwise, reduced on effort. Cardiac output, however, increased. 4 . The two effects of Apresoline, increase of renal blood flow and lowering of arterial blood pressure are not interdependent. SUMARIO ESPA~OL 1. A 12 pacientes con estenosis mitral se les administr6 Apresolina intravenosa en cantidades de 10 a 15 mg. a una velocidad promedio de 0.3 a 0.5 mg. por minuto. Simultaneamente se administr6 Noradrenalina a una velocidad promedio de 0.006 mg. por minuto para contrarrestar el efecto hipotonico de la Apresolina.
